EMD SERONO SPECIALTY DIGEST PDF

The 14th edition EMD Serono’s Specialty Digest continues its. Getting the picture of what’s happening now is the value of. Managed Markets, EMD Serono, Inc. Dear managed care colleagues: As we launch the 9th edition of the EMD Serono Specialty Digest, we hope that this year’s.

Author: Diran Banris
Country: Ecuador
Language: English (Spanish)
Genre: Life
Published (Last): 2 December 2011
Pages: 232
PDF File Size: 16.80 Mb
ePub File Size: 13.62 Mb
ISBN: 643-6-53907-710-2
Downloads: 46857
Price: Free* [*Free Regsitration Required]
Uploader: Zulugami

Increases in US Life Expectancy. A Decade of Advances. Decline in Death Rates. Medicines Improve Quality of Life. Cure Rates Are Rising. Reductions in Hep C Complications. Innovation in Rare Diseases. Drug Discovery and Development. Translating Science into Medicines. Drug Development Costs Doubling. Stepping Stones for Innovation.

The Complexity of Clinical Trials. Commercial Success of Approved Meds.

Medicines Offer Cost Containment. Powerful Tools to Reduce Spending. Use of Generic Medicines. US Access to Cancer Medicines.

  DAVID J PEERY AIRCRAFT STRUCTURES PDF

12th Edition of the EMD Serono Specialty Digestâ„¢ Now Available

Greater Access to Cancer Medicines. Clinical Factors Drive Presciptions.

Decline in New Medicine Returns. Patent Challenges by Generics. New Generics Are Adopted Regularly. Market for Is Medicines Changing. Pragmatic Solutions to Address Cost. Patient Cost Sharing Rising.

EMD Serono Specialty Digest, 9th Edition

High Cost Sharing Reduces Adherence. Patients Facing High Cost Sharing.

Medicine Spending in Next Decade. Slowdown in Medicine Spending.

PhRMA | Chart Packs

Brand Sales Face Competition. Total Health Care Spending Growth. Spending on Cancer Medicines. Growth in Medicine Prices. Rebates Reduced Price Growth.

Brand Medicine Spending Rebates. The Costs of Chronic Disease. Most Common Prescribing Problem. Better Use of Medicines. Value From Better Use of Medicines. Significant Value to Communities. State Targeting in Economic Plans. Leading in Intellectual Property. Venture Capital Fueling Innovation. Challenging the US in Innovation.